| Dec 5, 2025 |
Dec 5, 2025 |
Dyne Therapeutics, Inc.
|
CEO |
Sell |
47.5
|
-2,662
|
-0.98%
|
✓
|
$55.2K |
| Sep 5, 2025 |
Sep 9, 2025 |
Dyne Therapeutics, Inc.
|
CEO |
Sell |
51.3
|
-2,640
|
-0.96%
|
✓
|
$35.4K |
| Jul 14, 2025 |
Jul 15, 2025 |
Dyne Therapeutics, Inc.
|
CEO |
Buy |
97.5
|
+60,000
|
28.01%
|
✗
|
$911K |
| Jun 5, 2025 |
Jun 6, 2025 |
Dyne Therapeutics, Inc.
|
CEO |
Sell |
41.3
|
-4,060
|
-2.28%
|
✓
|
$54.2K |
| Mar 5, 2025 |
Mar 7, 2025 |
Dyne Therapeutics, Inc.
|
CEO |
Sell |
45.0
|
-4,061
|
-2.23%
|
✓
|
$48K |
| Sep 4, 2024 |
Sep 4, 2024 |
Dyne Therapeutics, Inc.
|
CEO |
Buy |
100.0
|
+32,000
|
640.00%
|
✗
|
$1.1M |
| Mar 24, 2020 |
Mar 26, 2020 |
REPLIGEN CORP
|
Director |
Sell |
22.5
|
-1,858
|
-66.81%
|
✗
|
$179.7K |
| Mar 18, 2020 |
Mar 20, 2020 |
REPLIGEN CORP
|
Director |
Sell |
17.5
|
-26,736
|
-90.58%
|
✗
|
$2.5M |
| Mar 4, 2020 |
Mar 5, 2020 |
REPLIGEN CORP
|
Director |
Sell |
20.0
|
-10,000
|
-78.24%
|
✗
|
$933.9K |
| Feb 24, 2020 |
Feb 26, 2020 |
REPLIGEN CORP
|
Director |
Sell |
20.0
|
-4,455
|
-61.57%
|
✗
|
$413.5K |
| Feb 23, 2016 |
Feb 25, 2016 |
BIOGEN INC.
|
EVP Pharmaceutical Oper & Tech |
Sell |
22.5
|
-382
|
-1.24%
|
✗
|
$98.9K |
| Feb 12, 2016 |
Feb 17, 2016 |
BIOGEN INC.
|
EVP Pharmaceutical Oper & Tech |
Sell |
20.0
|
-1,552
|
-2.56%
|
✗
|
$383.7K |
| Feb 8, 2016 |
Feb 9, 2016 |
BIOGEN INC.
|
EVP Pharmaceutical Oper & Tech |
Sell |
20.0
|
-1,324
|
-4.46%
|
✗
|
$332K |
| Mar 25, 2015 |
Mar 26, 2015 |
BIOGEN INC.
|
EVP Pharmaceutical Oper & Tech |
Sell |
3.8
|
-12,010
|
-31.96%
|
✓
|
$5.4M |
| Feb 12, 2015 |
Feb 17, 2015 |
BIOGEN INC.
|
EVP Pharmaceutical Oper & Tech |
Sell |
20.0
|
-1,761
|
-2.67%
|
✗
|
$690.5K |
| Feb 8, 2015 |
Feb 10, 2015 |
BIOGEN INC.
|
EVP Pharmaceutical Oper & Tech |
Sell |
17.5
|
-3,747
|
-6.01%
|
✗
|
$1.5M |
| Feb 23, 2014 |
Feb 25, 2014 |
BIOGEN INC.
|
EVP Pharmaceutical Oper & Tech |
Sell |
20.0
|
-1,228
|
-4.60%
|
✗
|
$426.3K |
| Feb 12, 2014 |
Feb 14, 2014 |
BIOGEN INC.
|
EVP Pharmaceutical Oper & Tech |
Sell |
20.0
|
-1,059
|
-4.21%
|
✗
|
$342.1K |
| Feb 8, 2014 |
Feb 11, 2014 |
BIOGEN INC.
|
EVP Pharmaceutical Oper & Tech |
Sell |
17.5
|
-3,653
|
-7.77%
|
✗
|
$1.2M |